<?xml version="1.0" encoding="UTF-8"?>
<ref id="B42-molecules-24-01552">
 <label>42.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Rutter</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Scherzer</surname>
    <given-names>T.-M.</given-names>
   </name>
   <name>
    <surname>Beinhardt</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Kerschner</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Stättermayer</surname>
    <given-names>A.F.</given-names>
   </name>
   <name>
    <surname>Hofer</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Popow-Kraupp</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Steindl-Munda</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Ferenci</surname>
    <given-names>P.</given-names>
   </name>
  </person-group>
  <article-title>Intravenous silibinin as ‘rescue treatment’ for on-treatment non-responders to pegylated interferon/ribavirin combination therapy</article-title>
  <source>Antivir. Ther.</source>
  <year>2011</year>
  <volume>16</volume>
  <fpage>1327</fpage>
  <lpage>1333</lpage>
  <pub-id pub-id-type="doi">10.3851/IMP1942</pub-id>
  <?supplied-pmid 22155914?>
  <pub-id pub-id-type="pmid">22155914</pub-id>
 </element-citation>
</ref>
